NCT02469103

Brief Summary

The purpose of this study is to investigate the accuracy of second generation colon capsule (C2) in evaluating colonic mucosal inflammation of ulcerative colitis patients, using conventional endoscopy as the gold standard.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2014

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2014

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

June 9, 2015

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 11, 2015

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2018

Completed
Last Updated

July 17, 2018

Status Verified

July 1, 2018

Enrollment Period

3.3 years

First QC Date

June 9, 2015

Last Update Submit

July 16, 2018

Conditions

Keywords

capsule colonoscopyulcerative colitis

Outcome Measures

Primary Outcomes (1)

  • Number of participants with extent and severity of colonic inflammation

    extent and severity of mucosal inflammation will be assessed by each investigation

    1 day

Study Arms (1)

C2 & colonoscopy

EXPERIMENTAL

C2 and colonoscopy

Device: C2Procedure: colonoscopy

Interventions

C2DEVICE

C2 and colonoscopy will be performed one after another on the same day

C2 & colonoscopy
colonoscopyPROCEDURE
C2 & colonoscopy

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • age 18-80 years
  • suspected or known UC
  • written informed consent

You may not qualify if:

  • patients with severe UC according to Truelove and Witts' criteria
  • current pregnancy/lactating
  • patients with a pacemaker or other implanted electromedical device
  • the presence of dysphagia
  • patients at higher risk of capsule retention (including Crohn's disease, small bowel tumor, radiation enteropathy, previous intestinal surgery, acute abdominal pain without regular defecation)
  • patients with a contraindication to bowel preparation (congestive heart failure, renal insufficiency, a life-threatening condition)
  • patients with an allergy to polyethylene glycol, sodium phosphate solution, metoclopramide or bisacodyl suppository

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Prince of Wales Hospital

Hong Kong, 0000, Hong Kong

Location

Related Publications (1)

  • Shi HY, Chan FKL, Higashimori A, Kyaw M, Ching JYL, Chan HCH, Chan JCH, Chan AWH, Lam KLY, Tang RSY, Wu JCY, Sung JJY, Ng SC. A prospective study on second-generation colon capsule endoscopy to detect mucosal lesions and disease activity in ulcerative colitis (with video). Gastrointest Endosc. 2017 Dec;86(6):1139-1146.e6. doi: 10.1016/j.gie.2017.07.007. Epub 2017 Jul 14.

MeSH Terms

Conditions

Colitis, Ulcerative

Interventions

Colonoscopy

Condition Hierarchy (Ancestors)

ColitisGastroenteritisGastrointestinal DiseasesDigestive System DiseasesInflammatory Bowel DiseasesColonic DiseasesIntestinal Diseases

Intervention Hierarchy (Ancestors)

Endoscopy, GastrointestinalEndoscopy, Digestive SystemDiagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Officials

  • Siew Ng

    Chinese University of Hong Kong

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

June 9, 2015

First Posted

June 11, 2015

Study Start

October 1, 2014

Primary Completion

January 1, 2018

Study Completion

January 1, 2018

Last Updated

July 17, 2018

Record last verified: 2018-07

Data Sharing

IPD Sharing
Will not share

Locations